These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23656734)

  • 1. Proteolytic activation transforms heparin cofactor II into a host defense molecule.
    Kalle M; Papareddy P; Kasetty G; Tollefsen DM; Malmsten M; Mörgelin M; Schmidtchen A
    J Immunol; 2013 Jun; 190(12):6303-10. PubMed ID: 23656734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
    Maekawa H; Sato H; Tollefsen DM
    Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the chemotactic activity of heparin cofactor II proteolysis products.
    Hoffman M; Pratt CW; Corbin LW; Church FC
    J Leukoc Biol; 1990 Aug; 48(2):156-62. PubMed ID: 2196322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of heparin cofactor II from human plasma.
    Toulon P; Chadeuf G; Aiach M
    J Chromatogr; 1991 Feb; 539(2):493-500. PubMed ID: 2045458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.
    Ikeda Y; Aihara K; Yoshida S; Iwase T; Tajima S; Izawa-Ishizawa Y; Kihira Y; Ishizawa K; Tomita S; Tsuchiya K; Sata M; Akaike M; Kato S; Matsumoto T; Tamaki T
    J Biol Chem; 2012 Oct; 287(41):34256-63. PubMed ID: 22904320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
    Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji).
    Kondo S; Tokunaga F; Kario K; Matsuo T; Koide T
    Blood; 1996 Feb; 87(3):1006-12. PubMed ID: 8562924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic changes and localization of plasma heparin cofactor II before and after delivery in hypertensive pregnancy].
    Chen X; Zhang G; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):468-70. PubMed ID: 11721410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.
    O'Keeffe D; Olson ST; Gasiunas N; Gallagher J; Baglin TP; Huntington JA
    J Biol Chem; 2004 Nov; 279(48):50267-73. PubMed ID: 15371417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y; Hayashi T; Lee JB; Ozawa T; Sakuragawa N
    J Biol Chem; 2000 Apr; 275(15):11379-82. PubMed ID: 10753952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated polysaccharide from the leaves of Artemisia Princeps activates heparin cofactor II independently of the Lys173 and Arg189 residues of heparin cofactor II.
    Hayashi T; Hayakawa Y; Hayashi T; Sasaki H; Sakuragawa N
    Thromb Res; 1997 Jul; 87(1):105-12. PubMed ID: 9253805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
    Han JH; Tollefsen DM
    Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
    Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
    BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
    Kamp P; Strathmann A; Ragg H
    Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
    Ciaccia AV; Monroe DM; Church FC
    J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
    Sarilla S; Habib SY; Kravtsov DV; Matafonov A; Gailani D; Verhamme IM
    J Biol Chem; 2010 Mar; 285(11):8278-89. PubMed ID: 20053992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
    Verhamme IM
    Anal Biochem; 2012 Feb; 421(2):489-98. PubMed ID: 22206940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.